Oryzon Genomics, S. A.

About Oryzon Genomics, S. A.

Oryzon is a public clinical stage biopharmaceutical company focused on developing innovative epigenetic personalized medicines for patients with cancer and CNS disorders. The company leverages epigenetics to discover and develop therapeutics through its epigenetic platform, aiming to translate biomarkers and therapeutic targets into advanced personalized therapies.

Products & Services

Iadademstat:A therapeutic program focused on epigenetic personalized medicine for cancer and CNS disorders.

Epigenetic Platform:A platform used to identify and validate biomarkers and therapeutic targets for developing personalized therapies.

Specialties

Epigenetics Personalized Medicine Cancer Therapeutics CNS Disorder Therapeutics LSD1 Research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 15000000 MR: - FA: 13,263,794 € FAN: 15000000	D: 2025-05-08 FD: 2025-05-08	2 investors
2	RT: Equity Financing T: - FT: Equity Financing	A: 30000000 MR: - FA: €30 million FAN: 30000000	D: 2025-04-24 FD: 2025-04-24	5 investors
3	RT: Grant T: - FT: Grant	A: 498690 MR: - FA: 498,690 USD FAN: 498690	D: 2023-12-04 FD: 2023-12-04	1 investors
4	RT: Convertible Bond T: - FT: Convertible Bond	A: 45000000 MR: - FA: Up to €45 million FAN: 45000000	D: 2023-11-21 FD: 2023-11-21	1 investors

Grant Latest

2025-05-08

$15.0M

2 investors (Pro only)

Equity Financing 2025-04-24

$30.0M

Grant 2023-12-04

$499K

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Carlos Buesa

Chief Executive Officer (CEO)

J

Jordi Xaus

Chief Scientific Officer

M

Michael Ropacki

Chief Medical Officer for CNS

S

Sonia Gutierrez

Chief of Clinical Operations

A

Ana Limón

Senior VicePresident of Clinical Development and Global Medical Affairs

E

Enric Rello

Chief Operating Officer (COO), Chief Financial Officer (CFO)

View 18 more team members with Pro

Unlock Full Team Directory

Recent News